Cargando…

Molecular mutations as a possible factor for determining extent of thyroid surgery

BACKGROUND: Molecular testing of thyroid nodules is a diagnostic tool used to better understand the nature of thyroid nodules. The aim of this study is to better comprehend the relationship between specific mutations and aggressive behavior of the tumour as demonstrated on postoperative pathological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krasner, Joshua R., Alyouha, Nourah, Pusztaszeri, Marc, Forest, Veronique-Isabelle, Hier, Michael P., Avior, Galit, Payne, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796357/ https://www.ncbi.nlm.nih.gov/pubmed/31623671 http://dx.doi.org/10.1186/s40463-019-0372-5

Ejemplares similares

Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review
por: Hier, Jessica, et al.
Publicado: (2021)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations
por: Alohali, Sama, et al.
Publicado: (2023)

EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles
por: Elsherbini, Noha, et al.
Publicado: (2022)

Characteristics of PTEN Mutation in Thyroid Tumours: A Retrospective Chart Review
por: Bandargal, Saruchi, et al.
Publicado: (2023)

Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?
por: Hudson, Thomas J., et al.
Publicado: (2023)

BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
por: Silver, Jennifer A., et al.
Publicado: (2021)

Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2022)

Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves’ disease patients: a retrospective matched cohort study
por: You, Eunice, et al.
Publicado: (2019)

Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada
por: Rajab, Mohannad, et al.
Publicado: (2022)

Prognostic Indicators of EIF1AX-Mutated Thyroid Tumor Malignancy and Cancer Aggressiveness
por: Bandargal, Saruchi, et al.
Publicado: (2022)

Surgical Outcomes of Thyroid Nodules Positive for Gene Expression Alterations Using ThyroSeq V3 Genomic Classifier
por: Salameh, Samer, et al.
Publicado: (2022)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
por: Turkdogan, Sena, et al.
Publicado: (2018)

SAT523 Molecular Profile of Local vs. Regional Aggressive Thyroid Cancer: A Multicenter Study
por: Tessler, Idit, et al.
Publicado: (2023)

The McGill Thyroid Nodule Score’s (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review
por: Khalife, Sarah, et al.
Publicado: (2016)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

Preoperative prediction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a Canadian single-Centre experience
por: Larouche, Vincent, et al.
Publicado: (2020)

Preoperative vocal cord paralysis and its association with malignant thyroid disease and other pathological features
por: Kay-Rivest, Emily, et al.
Publicado: (2015)

Coexisting Molecular Alterations Increase the Risk of Malignancy in Thyroid Nodules with Copy Number Alterations
por: Rajab, Mohannad, et al.
Publicado: (2022)

The Difference in Clinical Behavior of Gene Fusions Involving RET/PTC Fusions and THADA/IGF2BP3 Fusions in Thyroid Nodules
por: Tali, George, et al.
Publicado: (2023)

The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
por: Sasson, Mark, et al.
Publicado: (2017)

A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
por: Al Jassim, Abrar, et al.
Publicado: (2018)

Thyroidectomy for Graves’ Disease Predicts Postoperative Neck Hematoma and Hypocalcemia: A North American cohort study
por: Mohtashami, Sadaf, et al.
Publicado: (2021)

Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
por: Jozaghi, Yelda, et al.
Publicado: (2013)

The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
por: Jooya, Alborz, et al.
Publicado: (2016)

Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis
por: Tessler, Idit, et al.
Publicado: (2023)

Completion thyroidectomy: predicting bilateral disease
por: Ibrahim, Badr, et al.
Publicado: (2015)

Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?
por: Kaliszewski, Krzysztof, et al.
Publicado: (2016)

Increasing Thyroid Cancer Rate and the Extent of Thyroid Surgery in Korea
por: Sung, Myung-Whun, et al.
Publicado: (2014)

Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
por: Hosseini, S., et al.
Publicado: (2016)

The relationship between upper airway collapse and the severity of obstructive sleep apnea syndrome: a chart review
por: Schwartz, Russell N., et al.
Publicado: (2015)

SAT527 The Management Of Thyroid Cancer: Where We Started And Where We Are Heading? A Five-decades Text Mining Analysis
por: Tessler, Idit, et al.
Publicado: (2023)

Development and validation of the modified index of fragility in head and neck cancer surgery
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2023)

Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma
por: Zhao, Hengqiang, et al.
Publicado: (2021)

Continuing controversies on the extent of surgery in papillary thyroid carcinoma
por: Díez, Juan J.
Publicado: (2022)

Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma
por: Feng, Jia-Wei, et al.
Publicado: (2019)

The first Canadian experience with the Afirma® gene expression classifier test
por: Kay-Rivest, Emily, et al.
Publicado: (2017)

3-phase dual-energy CT scan as a feasible salvage imaging modality for the identification of non-localizing parathyroid adenomas: a prospective study
por: Roskies, Michael, et al.
Publicado: (2015)

H(2)O(2) Metabolism in Normal Thyroid Cells and in Thyroid Tumorigenesis: Focus on NADPH Oxidases
por: Szanto, Ildiko, et al.
Publicado: (2019)

Above and Beyond Age: Prediction of Major Postoperative Adverse Events in Head and Neck Surgery
por: Mascarella, Marco A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42st58b4mk1b2dan54ikg029b0